- Report
- February 2024
- 79 Pages
North America
From €3140EUR$3,450USD£2,692GBP
- Report
- February 2024
- 83 Pages
Africa, Middle East
From €3140EUR$3,450USD£2,692GBP
- Report
- February 2024
- 95 Pages
Europe
From €3140EUR$3,450USD£2,692GBP
- Report
- February 2024
- 91 Pages
Asia Pacific
From €3140EUR$3,450USD£2,692GBP
- Report
- September 2023
- 173 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- June 2023
- 115 Pages
United States
From €3140EUR$3,450USD£2,692GBP
- Report
- January 2022
- 148 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- November 2023
- 178 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- July 2023
- 110 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- December 2022
- 119 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- August 2022
- 112 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- November 2021
- 114 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- July 2022
- 27 Pages
Global
From €3636EUR$3,995USD£3,117GBP
- Report
- January 2021
- 245 Pages
Global
From €3276EUR$3,600USD£2,809GBP
- Report
- August 2022
- 115 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 140 Pages
Global
From €3275EUR$3,599USD£2,808GBP
- Report
- September 2023
- 200 Pages
Global
From €3275EUR$3,599USD£2,808GBP
- Report
- April 2024
- 140 Pages
Global
From €4522EUR$4,969USD£3,877GBP
- Report
- June 2023
- 160 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Report
- May 2023
- 147 Pages
Global
From €4504EUR$4,949USD£3,861GBP

Diabetic Retinopathy (DR) is a medical condition that affects the eyes of people with diabetes. It is caused by damage to the blood vessels in the retina, the light-sensitive layer of tissue at the back of the eye. DR can lead to vision loss and blindness if left untreated.
Optical imaging technologies, such as optical coherence tomography (OCT) and fundus photography, are used to diagnose and monitor DR. These technologies allow for early detection and treatment of DR, which can help to reduce the risk of vision loss.
In addition to imaging technologies, there are a number of treatments available for DR, including laser photocoagulation, intravitreal injections, and vitrectomy. These treatments can help to reduce the risk of vision loss and improve vision in those with DR.
The DR market is a rapidly growing market, driven by the increasing prevalence of diabetes and the need for early detection and treatment of DR.
Companies in the DR market include Carl Zeiss Meditec, Topcon Corporation, Optos, Nidek, and Heidelberg Engineering. Show Less Read more